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The Corona virus disease 2019 (Covid-19) has brought a wide range of challenges in
intensive care medicine. Understanding of the pathophysiology of Covid-19 relies on
interpreting of its impact on the vascular, particularly microcirculatory system. Herein we
report on the first use of the latest generation hand-held vital microscope to evaluate the
sublingual microcirculation in a Covid-19 patient with subcutaneous emphysema, venous
thrombosis and pneumomediastinum. Remarkably, microcirculatory parameters of the
patient were increased during the exacerbation period, which is not a usual finding in
critically ill patients mostly presenting with a loss of hemodynamic coherence. In contrast,
recovery from the disease led to a subsequent amelioration of these parameters. This
report clearly shows the importance of microcirculatory monitoring for evaluating the
course and the adequacy of therapy in Covid-19 patients.
Keywords: COVID-19, pneumomediastinum, venous thrombosis, subcutaneous emphysema, sublingual
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INTRODUCTION
The Corona virus disease 2019 (Covid-19) has brought a wide range of challenges in intensive care
medicine. Understanding of the pathophysiology of Covid-19 primarily relies on interpreting of its
effects on the vascular, particularly microcirculatory system (1).
In critically ill, microcirculatory alterations can be directly visualized at the bedside via handheld
vital microscopy (HVM) (2). HVM devices, equipped with imaging techniques such as orthogonal
polarization spectral (OPS) imaging and side-stream dark field (SDF) or incident dark field
(IDF) imaging, have enabled real time microvascular monitoring in this cohort. Accordingly,
microcirculatory alterations have been identified in advance of changes in systemic hemodynamic
parameters in many clinical settings that are associated with cardiovascular compromise such as
cardiac surgery and sepsis (3). Among HVM devices, Cytocam represents the newest generation
IDF microscope which provides better image quality than the initially used devices (4).
Herein, we applied this technology to directly observe the sublingual microcirculation in a
Covid-19 patient with subcutaneous emphysema, venous thrombosis and pneumomediastinum.
Grewal et al. Case Report: Microcirculatory Response to Covid-19
CASE REPORT
A 56-year-old man was admitted to our institution with an
11-day history of persistent dry cough, fever, and progressive
shortness of breath. On arrival at the hospital, he was hypoxemic,
with a SpO2 of 91% and a respiratory rate of 35 breaths per
minute requiring ambient oxygen therapy with a flow of 15 L/min
via a non-rebreathermask. Hemodynamically, he showed a stable
profile with a blood pressure of 120/80 mmHg and a heart
rate of 84 bpm. His body temperature was 38.1◦C. Laboratory
tests revealed an elevated C-reactive protein concentration of 37
mg/L (reference: <5 mg/L), a leukocyte count of 7.7 × 109/L
(reference: 4–10 × 109/L) and D-dimer of 0.41 mg/L (reference:
<0.50 mg/L). The chest radiograph demonstrated bilateral basal
consolidations. The suspicion of Covid-19 was confirmed by real-
time reverse transcription polymerase chain reaction (RT-PCR)
analysis of nasopharyngeal swab samples.
The patient was primarily admitted to a designated Covid-
19 ward for further observation and oxygen therapy. Due to
severe hypoxemic respiratory failure within 24 h after admission,
he was immediately transferred to the intensive care unit (ICU)
where he was intubated. On the 5th day of ICU admission
(T0), the patient developed a high fever accompanied with an
increase in inflammatory parameters (Table 1). Hemodynamic
parameters did not indicate an unstable course (Table 1).
Microcirculatory monitoring was carried out sublingually using
Cytocam-IDF imaging (CytoCam, Braedius Medical, Huizen,
The Netherlands). Image analysis which was performed offline
using MicroTools, showed an increase in microcirculatory
density (total vessel density and perfused vessel density) and
perfusion parameters (proportion of perfused vessels and
microvascular mean flow index) as well as in red blood cell (RBC)
velocity (Table 2). Subsequent CT-scan demonstrated extensive
subcutaneous emphysema and pneumomediastinum as well as a
thrombus in the right jugular vein extending to the superior vena
cava and into the right brachial vein (Figure 1). A tracheal defect
was ruled out by bronchoscopy. There was no pneumothorax or
evidence of esophageal rupture.
The patient was ventilated for 19 days and a temporary
tracheostomy was performed for a gradual wean from the
ventilator. Unfractionated heparin was given in therapeutic doses
for his venous thrombus. Chest CT obtained at 19th (T1) and
25th day of ICU admission (T2) showed complete resorption
of mediastinal air and venous thrombus (Figure 1). Concurrent
microcirculatory images revealed a recovery of microcirculatory
alterations (Table 2 and Figure 1). Thereupon on the 30th day of
ICU admission, the tracheostomy was removed and the patient
was discharged to the ward after 32 days of ICU stay in stable
hemodynamic and respiratory condition.
DISCUSSION
To our knowledge this is the first case report demonstrating
microcirculatory alterations in a Covid-19 patient with
subcutaneous emphysema and pneumomediastinum.
Remarkably, microcirculatory parameters and RBC velocity
of the patient showed an increase during the exacerbation
period, which is not a usual finding in critically ill patients
TABLE 1 | Case timeline.
Variable T0 T1 T2
Day of onset of Covid-19 symptoms 16 30 36
Day of intensive care unit admission 5 19 25
Heart rate, beats/min 81 129 106
Mean arterial pressure, mmHg 105/56 126/61 136/79
PaO2/FiO2, mmHg 115.5 112.5 174.3
Mode of ventilation PCV PCV PSV
Tidal volume, ml 450 348 446
Positive end-expiratory pressure, cmH2O 16 6 5
Fraction of inspired oxygen, % 50 50 40
Driving pressure, cmH2O 14 24 9
Compliance respiratory system, ml/cmH2O 18.8 14.5 27
Temperature, ◦C 37.5 37.2 38.3
Fluid balance, ml 270 −2,000 −2,600
Creatinine, µmol/L 75 96 48
C-reactive protein, mg/L 213 226 382
Hematocrit, % 41 30 34
Thrombocyte count, ×109/L 473 483 144
Leukocyte count, ×109/L 14.2 17.8 16.3
pH 7.46 7.32 7.36
PaCO2, kPa 5.8 7.7 8.4
PaO2, kPa 7.7 7.5 9.3
Bicarbonate, mmol/L 30 27 31
Base excess, mmol/L 6.7 3.7 8.8
Oxygen saturation, % 90 90 94
Lactate, mmol/L 1.9 0.6 0.8
T, time point; COVID-19, Coronavirus Disease 2019; PaCO2, partial pressure of carbon
dioxide; PaO2, partial pressure of oxygen; PCV, pressure-controlled ventilation; PSV,
pressure-supported ventilation.
TABLE 2 | Microcirculatory parameters.
Variable T0 T1 T2
FCD, mm/mm2 29.61 ± 0.92 28.02 ± 3.0 21.74 ± 3.84
PPV, % 95 ± 2 96 ± 2 98 ± 1
RBCv, µm/s 298.13 ± 19.61 327.10 ±18.89 354.81 ± 23.89
TVD, mm/mm2 31.24 ± 1.24 29.23 ± 2.67 22.15 ± 3.82
Values are presented as mean ± standard deviation.
T, time point; FCD, functional capillary density; PPV, proportion of perfused vessels; RBCv,
red blood cell velocity; TVD, total vessel density.
mostly presenting with a loss of hemodynamic coherence (3).
In contrast, recovery from the disease led to a subsequent
amelioration of these parameters.
The increase in microcirculatory parameters and RBC velocity
in this patient may be explained by an intact compensatory
mechanism of the microcirculation capable of responding
to hypoxia (5). This compensatory mechanism is aimed at
increasing the oxygen extraction capacity of the microcirculation
by decreasing diffusion distances between capillaries (increased
TVD) and by increasing convection of RBCs (increased RBC
flow). Similar microcirculatory response to hypoxia has been
reported in recent microcirculation studies which demonstrated
increased sublingual microcirculatory vessel density as a response
to hypoxic conditions at high altitude (6, 7). Notably, this intact
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FIGURE 1 | Chest CT (A) and microcirculatory images (B) obtained at 5th (T0), 19th (T1), and 25th (T2) day of intensive care admission.
compensatory mechanism may also explain the ability of Covid-
19 patients to cope with low levels of oxygen which has been
described as “happy hypoxia” (8).
Indeed, contrary to our results, Edul et al. (9) showed a decline
in RBC velocity accompanied by an increase in vessel density
in patients suffering from Covid-19 pneumonia. Furthermore,
Rovas et al. (10) noted reductions in RBC velocity with decreases
in vessel density in this cohort. Since hypoxemia induces both
capillary recruitment and angiogenesis (9), differences might be
related to the higher compromise of pulmonary oxygenation
in our patient [PaO2/FiO2 ratio, 112.5 mmHg vs. 122 ± 43
mmHg (9) vs. 194.88 (145.76–234.0) mmHg (10)]. Spontaneous
pneumomediastinum associated with Covid-19 has occasionally
been reported (11). The presumed etiology involves a virus
induced diffuse alveolar damage during an increase in intra-
alveolar pressure, leading to alveolar rupture, a mechanism
known as the Macklin effect (12). Ultimately, this pathology
together with venous thrombus might have also influenced
microcirculatory parameters in our patient, amplifying the
microcirculatory response to hypoxia. Furthermore, the increase
in microcirculatory parameters might have only been caused by
these pathologies.
The main limitation of our study concerns the small
sample size, thus making it difficult to generalize conclusions.
Although in our patient a spontaneous pneumomediastinum
was associated with a severe course of COVID-19 pneumonia,
it is yet unclear to what extend the increase in microcirculatory
parameters might predict the severity of disease in Covid-
19 patients who don’t present with pneumomediastinum.
Notwithstanding the limitations of our study, we obtained a
valuable patient perspective. Overall, our patient felt well and did
not have any complications. Remarkably, he appreciated the care
he received in our hospital.
In conclusion, this report clearly shows the importance of
microcirculatory monitoring for evaluating the course and the
adequacy of therapy in Covid-19 patients. Future studies are
warranted to assess whether microcirculatory parameters could
find potential clinical use as a predictor of the severity of disease
in this cohort.
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